Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin - Protein ligase with monoubiquitylation capacity

Human Molecular Genetics

Volumn 15, Issue 13, 2006, Pages 2059-2075

  Hampe, Cornelia ^a   Ardila Osorio, Hector ^a   Fournier, Margot ^a   Brice, Alexis ^a,b   Corti, Olga ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; MITOGEN ACTIVATED PROTEIN KINASE P38; PARKIN; POLYUBIQUITIN; PROTEASOME; UBIQUITIN PROTEIN LIGASE E3;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; GENE IDENTIFICATION; GENE MUTATION; GENETIC CODE; GENETIC CONSERVATION; IN VITRO STUDY; MUTATIONAL ANALYSIS; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN VARIANT; TRANSLATION REGULATION; UBIQUITINATION;

AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; ANIMALS; CELL-FREE SYSTEM; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MUTANT PROTEINS; MUTATION; MUTATION, MISSENSE; PARKINSON DISEASE; PLASMIDS; POINT MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SOLUBILITY; TRANSFECTION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

MAMMALIA;

EID: 33745280651     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddl131     Document Type: Article

References (95)

1. de Rijk, M.C., Tzourio, C., Breteler, M.M., Dartigues, J.F., Amaducci, L., Lopez-Pousa, S., Manubens-Bertran, J.M., Alperovitch, A. and Rocca, W.A. (1997) Prevalence of parkinsonism and Parkinson's disease in Europe: The EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J. Neurol. Neurosurg. Psychiat., 62, 10-15.
2. Forno, L.S. (1996) Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol., 55, 259-272.
3. Gasser, T. (2005) Genetics of Parkinson's disease. Curr. Opin. Neurol., 18, 363-369.
4. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R.J., Calne, D.B. et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron, 44, 601-607.
5. Paisan-Ruiz, C., Jain, S., Evans, E.W., Gilks, W.P., Simon, J., Van Der, B.M., Lopez, D.M., Aparicio, S., Gil, A.M., Khan, N. et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron, 44, 595-600.
6. Di Fonzo, A., Rohe, C.F., Ferreira, J., Chien, H.F., Vacca, L., Stocchi, F., Guedes, L., Fabrizio, E., Manfredi, M., Vanacore, N. et al. (2005) A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet, 365, 412-415.
7. Nichols, W.C., Pankratz, N., Hernandez, D., Paisan-Ruiz, C., Jain, S., Halter, C.A., Michaels, V.E., Reed, T., Rudolph, A., Shults, C.W. et al. (2005) Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet, 365, 410-412.
8. Kachergus, J., Mata, I.F., Hulihan, M., Taylor, J.P., Lincoln, S., Aasly, J., Gibson, J.M., Ross, O.A., Lynch, T., Wiley, J. et al. (2005) Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: Evidence of a common founder across European populations. Am. J. Hum. Genet., 76, 672-680.
9. Bras, J.M., Guerreiro, R.J., Ribeiro, M.H., Januario, C., Morgadinho, A., Oliveira, C.R., Cunha, L., Hardy, J. and Singleton, A. (2005) G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. Mov. Disord., 20, 1653-1655.
10. Lesage, S., Ibanez, P., Lohmann, E., Pollak, P., Tison, F., Tazir, M., Leutenegger, A.L., Guimaraes, J., Bonnet, A.M., Agid, Y. et al. (2005) G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Ann. Neurol., 58, 784-787.
11. Brice, A. (2005) How much does dardarin contribute to Parkinson's disease? Lancet, 365, 363-364.
12. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608.
13. Lucking, C.B., Durr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B.S., Meco, G., Denefle, P., Wood, N.W. et al. (2000) Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N. Engl. J. Med., 342, 1560-1567.
14. West, A.B. and Maidment, N.T. (2004) Genetics of parkin-linked disease. Hum. Genet., 114, 327-336.
15. Periquet, M., Latouche, M., Lohmann, E., Rawal, N., De Michele, G., Ricard, S., Teive, H., Fraix, V., Vidailhet, M., Nicholl, D. et al. (2003) Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain, 126, 1271-1278.
16. Klein, C., Pramstaller, P.P., Kis, B., Page, C.C., Kann, M., Leung, J., Woodward, H., Castellan, C.C., Scherer, M., Vieregge, P. et al. (2000) Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: Expanding the phenotype. Ann. Neurol., 48, 65-71.
17. van de Warrenburg, B.P., Lammens, M., Lucking, C.B., Denefle, P., Wesseling, P., Booij, J., Praamstra, P., Quinn, N., Brice, A. and Horstink, M.W. (2001) Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology, 56, 555-557.
18. Tassin, J., Durr, A., Bonnet, A.M., Gil, R., Vidailhet, M., Lucking, C.B., Goas, J.Y., Durif, F., Abada, M., Echenne, B. et al. (2000) Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? Brain, 123, 1112-1121.
19. Pramstaller, P.P., Schlossmacher, M.G., Jacques, T.S., Scaravilli, F., Eskelson, C., Pepivani, I., Hedrich, K., Adel, S., Gonzales-McNeal, M., Hilker, R. et al. (2005) Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann. Neurol., 58, 411-422.
20. Sasaki, S., Shirata, A., Yamane, K. and Iwata, M. (2004) Parkin-positive autosomal recessive juvenile Parkinsonism with alpha-synuclein-positive inclusions. Neurology, 63, 678-682.
21. Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K. and Mizuno, Y. (1998) Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology, 51, 890-892.
22. Hayashi, S.,Wakabayashi,K., Ishikawa,A.,Nagai,H., Saito,M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S. and Takahashi, H. (2000) An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov. Disord., 15, 884-888.
23. Gouider-Khouja, N., Larnaout, A., Amouri, R., Sfar, S., Belal, S., Ben Hamida, C., Ben Hamida, M., Hattori, N., Mizuno, Y. and Hentati, F. (2003) Autosomal recessive parkinsonism linked to parkin gene in a Tunisian family. Clinical, genetic and pathological study. Parkinsonism. Relat. Disord., 9, 247-251.
24. Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn-Hardy, K., Petrucelli, L., Hussey, J. et al. (2001) Lewy bodies and parkinsonism in families with parkin mutations. Ann. Neurol., 50, 293-300.
25. Lohmann, E., Periquet, M., Bonifati, V., Wood, N.W., De Michele, G., Bonnet, A.M., Fraix, V., Broussolle, E., Horstink, M.W., Vidailhet, M. et al. (2003) How much phenotypic variation can be attributed to parkin genotype? Ann. Neurol., 54, 176-185.
26. Shimura, H., Hattori, N., Kubo, S.,Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. and Suzuki, T. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet., 25, 302-305.
27. Junn, E., Lee, S.S., Suhr, U.T. and Mouradian, M.M. (2002) Parkin accumulation in aggresomes due to proteasome impairment. J. Biol. Chem., 277, 47870-47877.
28. Ardley, H.C., Scott, G.B., Rose, S.A., Tan, N.G., Markham, A.F. and Robinson, P.A. (2003) Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin. Mol. Biol. Cell, 14, 4541-4556.
29. Muqit, M.M., Davidson, S.M., Payne, S., MacCormac, L.P., Kahns, S., Jensen, P.H., Wood, N.W. and Latchman, D.S. (2004) Parkin is recruited into aggresomes in a stress-specific manner: Over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival. Hum. Mol. Genet., 13, 117-135.
30. Gu, W.J., Corti, O., Araujo, F., Hampe, C., Jacquier, S., Lucking, C.B., Abbas, N., Duyckaerts, C., Rooney, T., Pradier, L. et al. (2003) The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates. Neurobiol. Dis., 14, 357-364.
31. Cookson, M.R., Lockhart, P.J., McLendon, C., O'Farrell, C., Schlossmacher, M. and Farrer, M.J. (2003) RING finger 1 mutations in Parkin produce altered localization of the protein. Hum. Mol. Genet., 12, 2957-2965.
32. Sriram, S.R., Li, X., Ko, H.S., Chung, K.K., Wong, E., Lim, K.L., Dawson, V.L. and Dawson, T.M. (2005) Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin. Hum. Mol. Genet., 14, 2571-2586.
33. Wang, C., Tan, J.M., Ho, M.W., Zaiden, N., Wong, S.H., Chew, C.L., Eng, P.W., Lim, T.M., Dawson, T.M. and Lim, K.L. (2005) Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease-linked point mutations. J. Neurochem., 93, 422-431.
34. Henn, I.H., Gostner, J.M., Lackner, P., Tatzelt, J. and Winklhofer, K.F. (2005) Pathogenic mutations inactivate parkin by distinct mechanisms. J. Neurochem., 92, 114-122.
35. Winklhofer, K.F., Henn, I.H., Kay-Jackson, P.C., Heller, U. and Tatzelt, J. (2003) Inactivation of parkin by oxidative stress and C-terminal truncations: A protective role of molecular chaperones. J. Biol. Chem., 278, 47199-47208.
36. Wang, C., Ko, H.S., Thomas, B., Tsang, F., Chew, K.C., Tay, S.P., Ho, M.W., Lim, T.M., Soong, T.W., Pletnikova, O. et al. (2005) Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function. Hum. Mol. Genet., 14, 3885-3897.
37. Zhao, J., Ren, Y., Jiang, Q. and Feng, J. (2003) Parkin is recruited to the centrosome in response to inhibition of proteasomes. J. Cell Sci., 116, 4011-4019.
38. Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. and Dawson, T.M. (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl Acad. Sci. USA, 97, 13354-13359.
39. Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. and Takahashi, R. (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell, 105, 891-902.
40. Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. and Selkoe, D.J. (2001) Ubiquitination of a new form of alpha-synuclein by parkin from human brain: Implications for Parkinson's disease. Science, 293, 263-269.
41. Corti, O., Hampe, C., Koutnikova, H., Darios, F., Jacquier, S., Prigent, Robinson, J.C., Pradier, L., Ruberg, M., Mirande, M. et al. (2003) The subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum. Mol. Genet., 12, 1427-1437.
42. Huynh, D.P., Scoles, D.R., Nguyen, D. and Pulst, S.M. (2003) The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum. Mol. Genet., 2587-2597.
43. Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. and Dawson, T.M. (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: Implications for Lewy-body formation in Parkinson disease. Nat. Med., 7, 1144-1150.
44. Jiang, H., Jiang, Q. and Feng, J. (2004) Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter. J. Biol. Chem., 279, 54380-54386.
45. Staropoli, J.F., McDermott, C., Martinat, C., Schulman, B., Demireva, E. and Abeliovich, A. (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron, 37, 735-749.
46. Ren, Y., Zhao, J. and Feng, J. (2003) Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation. J. Neurosci., 23, 3316-3324.
47. Tsai, Y.C., Fishman, P.S., Thakor, N.V. and Oyler, G.A. (2003) Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J. Biol. Chem., 278, 22044-22055.
48. Ko, H.S., von Coelln, R., Sriram, S.R., Kim, S.W., Chung, K.K., Pletnikova, O., Troncoso, J., Johnson, B., Saffary, R., Goh, E.L. et al. (2005) Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J. Neurosci., 25, 7968-7978.
49. Sun, L. and Chen, Z.J. (2004) The novel functions of ubiquitination signaling. Curr. Opin. Cell Biol., 16, 119-126.
50. d'Azzo, A., Bongiovanni, A. and Nastasi, T. (2005) E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation. Traffic, 6 429-441.
51. Choi, P., Snyder, H., Petrucelli, L., Theisler, C., Chong, M., Zhang, Y., Lim, K., Chung, K.K., Kehoe, K., D'Adamio, L. et al. (2003) SEPT5_v2 is a parkin-binding protein. Brain Res. Mol. Brain Res., 117, 179-189.
52. Murakami, T., Shoji, M., Imai, Y., Inoue, H., Kawarabayashi, T., Matsubara, E., Harigaya, Y., Sasaki, A., Takahashi, R. and Abe, K. (2004) Pael-R is accumulated in Lewy bodies of Parkinson's disease. Ann. Neurol., 55, 439-442.
53. Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C.A. and Takahashi, H. (2000) Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann. Neurol., 47, 521-523.
54. Galloway, P.G., Grundke-Iqbal, I., Iqbal, K. and Perry, G. (1988) Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. J. Neuropathol. Exp. Neurol., 47, 654-663.
55. Lim, K.L., Chew, K.C., Tan, J.M., Wang, C., Chung, K.K., Zhang, Y., Tanaka, Y., Smith, W., Engelender, S., Ross, C.A. et al. (2005) Parkin mediates non-classical, proteasomal-independent ubiquitination of synphilin-1: Implications for Lewy body formation. J. Neurosci., 25, 2002-2009.
56. Doss-Pepe, E.W., Chen, L. and Madura, K. (2005) Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains. J. Biol. Chem., 280, 16619-16624.
57. Matsuda, N., Kitami, T., Suzuki, T., Mizuno, Y., Hattori, N. and Tanaka, K. (2006) Diverse effects of pathogenic mutations of Parkin that catalyzes multiple monoubiquitylation in vitro. J. Biol. Chem., 281, 3204-3209.
58. Schlossmacher, M.G., Frosch, M.P., Gai, W.P., Medina, M., Sharma, N., Forno, L., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N. et al. (2002) Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am. J. Pathol., 160, 1655-1667.
59. Yang, F., Jiang, Q., Zhao, J., Ren, Y., Sutton, M.D. and Feng, J. (2005) Parkin stabilizes microtubules through strong binding mediated by three independent domains. J. Biol. Chem., 280, 17154-17162.
60. Dachsel, J.C., Lucking, C.B., Deeg, S., Schultz, E., Lalowski, M., Casademunt, E., Corti, O., Hampe, C., Patenge, N., Vaupel, K. et al. (2005) Parkin interacts with the proteasome subunit alpha4. FEBS Lett., 579, 3913-3919.
61. Imai, Y., Soda, M. and Takahashi, R. (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem., 275, 35661-35664.
62. Sato, S., Chiba, T., Sakata, E., Kato, K., Mizuno, Y., Hattori, N. and Tanaka, K. (2006) 14-3-Beta is a novel regulator of parkin ubiquitin ligase. EMBO J., 25, 211-221.
63. Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, K.I. and Takahashi, R. (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell, 10, 55-67.
64. Okui, M., Yamaki, A., Takayanagi, A., Kudoh, J., Shimizu, N. and Shimizu, Y. (2005) Transcription factor single-minded 2 (SIM2) is ubiquitinated by the RING-IBR-RING-type E3 ubiquitin ligases. Exp. Cell Res., 309, 220-228.
65. Hatakeyama, S., Yada, M., Matsumoto, M., Ishida, N. and Nakayama, K.I. (2001) U box proteins as a new family of ubiquitin-protein ligases. J. Biol. Chem., 276, 33111-33120.
66. Lorick, K.L., Jensen, J.P., Fang, S., Ong, A.M., Hatakeyama, S. and Weissman, A.M. (1999) RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl Acad. Sci. USA, 96, 11364-11369.
67. Fang, S., Jensen, J.P., Ludwig, R.L., Vousden, K.H. and Weissman, A.M. (2000) Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem., 275, 8945-8951.
68. Wu-Baer, F., Lagrazon, K., Yuan, W. and Baer, R. (2003) The BRCA1/ BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin. J. Biol. Chem., 278, 34743-34746.
69. Capili, A.D., Edghill, E.L., Wu, K. and Borden, K.L. (2004) Structure of the C-terminal RING finger from a RING-IBR-RING/TRIAD motif reveals a novel zinc-binding domain distinct from a RING. J. Mol. Biol., 340, 1117-1129.
70. Zhong, L., Tan, Y., Zhou, A., Yu, Q. and Zhou, J. (2005) RING finger ubiquitin-protein isopeptide ligase Nrdp1/FLRF regulates parkin stability and activity. J. Biol. Chem., 280, 9425-9430.
71. Raiborg, C., Rusten, T.E. and Stenmark, H. (2003) Protein sorting into multivesicular endosomes. Curr. Opin. Cell Biol., 15, 446-455.
72. Kalia, S.K., Lee, S., Smith, P.D., Liu, L., Crocker, S.J., Thorarinsdottir, T.E., Glover, J.R., Fon, E.A., Park, D.S. and Lozano, A.M. (2004) BAG5 inhibits parkin and enhances dopaminergic neuron degeneration. Neuron, 44, 931-945.
73. Terreni, L., Calabrese, E., Calella, A.M., Forloni, G. and Mariani, C. (2001) New mutation (R42P) of the parkin gene in the ubiquitin-like domain associated with parkinsonism. Neurology, 56, 463-466.
74. Hedrich, K., Marder, K., Harris, J., Kann, M., Lynch, T., Meija-Santana, H., Pramstaller, P.P., Schwinger, E., Bressman, S.B., Fahn, S. and Klein, C. (2002) Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology, 58, 1239-1246.
75. Bertoli-Avella, A.M., Giroud-Benitez, J.L., Akyol, A., Barbosa, E., Schaap, O., van der Linde, H.C., Martignoni, E., Lopiano, L., Lamberti, P., Fincati, E. et al. (2005) Novel parkin mutations detected in patients with early-onset Parkinson's disease. Mov. Disord., 20, 424-431.
76. Oliveira, S.A., Scott, W.K., Martin, E.R., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Pahwa, R., Stern, M.B., Hiner, B.C. et al. (2003) Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann. Neurol., 53, 624-629.
77. West, A., Periquet, M., Lincoln, S., Lucking, C.B., Nicholl, D., Bonifati, V., Rawal, N., Gasser, T., Lohmann, E., Deleuze, J.F. et al. (2002) Complex relationship between Parkin mutations and Parkinson disease. Am. J. Med. Genet., 114, 584-591.
78. Lincoln, S.J.,Maraganore, D.M., Lesnick, T.G., Bounds, R., de Andrade,M., Bower, J.H., Hardy, J.A. and Farrer, M.J. (2003) Parkin variants in North American Parkinson's disease: Cases and controls. Mov. Disord., 18, 1306-1311.
79. Schlitter, A.M., Kurz, M., Larsen, J.P., Woitalla, D., Muller, T., Epplen, J.T. and Dekomien, G. (2006) Parkin gene variations in late-onset Parkinson's disease: Comparison between Norwegian and German cohorts. Acta Neurol. Scand., 113, 9-13.
80. Hedrich, K., Kann, M., Lanthaler, A.J., Dalski, A., Eskelson, C., Landt, O., Schwinger, E., Vieregge, P., Lang, A.E., Breakefield, X.O. et al. (2001) The importance of gene dosage studies: Mutational analysis of the parkin gene in early-onset parkinsonism. Hum. Mol. Genet., 10, 1649-1656.
81. Abbas, N., Lucking, C.B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J.R., Gasser, T., Marconi, R. et al. (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum. Mol. Genet., 8, 567-574.
82. Periquet, M., Lucking, C., Vaughan, J., Bonifati, V., Durr, A., De Michele, G., Horstink, M., Farrer, M., Illarioshkin, S.N., Pollak, P. et al. (2001) Origin of the mutations in the parkin gene in Europe: Exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. Am. J. Hum. Genet., 68, 617-626.
83. Kann, M., Jacobs, H., Mohrmann, K., Schumacher, K., Hedrich, K., Garrels, J., Wiegers, K., Schwinger, E., Pramstaller, P.P., Breakefield, X.O. et al. (2002) Role of parkin mutations in 111 community-based patients with early-onset parkinsonism. Ann. Neurol., 51, 621-625.
84. Nichols, W.C., Pankratz, N., Uniacke, S.K., Pauciulo, M.W., Halter, C., Rudolph, A., Conneally, P.M. and Foroud, T. (2002) Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive Parkinson's disease families. J. Med. Genet., 39, 489-492.
85. Foroud, T., Uniacke, S.K., Liu, L., Pankratz, N., Rudolph, A., Halter, C., Shults, C., Marder, K., Conneally, P.M. and Nichols, W.C. (2003) Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology, 60, 796-801.
86. Shyu, W.C., Lin, S.Z., Chiang, M.F., Pang, C.Y., Chen, S.Y., Hsin, Y.L., Thajeb, P., Lee, Y.J. and Li, H. (2005) Early-onset Parkinson's disease in a Chinese population: 99mTc-TRODAT-1 SPECT, Parkin gene analysis and clinical study. Parkinsonism. Relat. Disord., 11, 173-180.
87. Khan, N.L., Graham, E., Critchley, P., Schrag, A.E., Wood, N.W., Lees, A.J., Bhatia, K.P. and Quinn, N. (2003) Parkin disease: A phenotypic study of a large case series. Brain, 126, 1279-1292.
88. Khan, N.L., Scherfler, C., Graham, E., Bhatia, K.P., Quinn, N., Lees, A.J., Brooks, D.J., Wood, N.W. and Piccini, P. (2005) Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation. Neurology, 64, 134-136.
89. Lincoln, S., Wiley, J., Lynch, T., Langston, J.W., Chen, R., Lang, A., Rogaeva, E., Sa, D.S., Munhoz, R.P., Harris, J. et al. (2003) Parkin-proven disease: Common founders but divergent phenotypes. Neurology, 60, 1605-1610.
90. Wiley, J., Lynch, T., Lincoln, S., Skipper, L., Hulihan, M., Gosal, D., Bisceglio, G., Kachergus, J., Hardy, J. and Farrer, M.J. (2004) Parkinson's disease in Ireland: Clinical presentation and genetic heterogeneity in patients with parkin mutations. Mov. Disord., 19, 677-681.
91. Thobois, S., Ribeiro, M.J., Lohmann, E., Durr, A., Pollak, P., Rascol, O., Guillouet, S., Chapoy, E., Costes, N., Agid, Y. et al. (2003) Young-onset Parkinson disease with and without parkin gene mutations: A fluorodopa F 18 positron emission tomography study. Arch. Neurol., 60, 713-718.
92. Pramstaller, P.P., Kunig, G., Leenders, K., Kann, M., Hedrich, K., Vieregge, P., Goetz, C.G. and Klein, C. (2002) Parkin mutations in a patient with hemiparkinsonism-hemiatrophy: A clinical-genetic and PET study. Neurology, 58, 808-810.
93. Hedrich, K., Eskelson, C., Wilmot, B., Marder, K., Harris, J., Garrels, J., Meija-Santana, H., Vieregge, P., Jacobs, H., Bressman, S.B. et al. (2004) Distribution, type, and origin of Parkin mutations: Review and case studies. Mov. Disord., 19, 1146-1157.
94. Sinha, R., Racette, B., Perlmutter, J.S. and Parsian, A. (2005) Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease. Parkinsonism. Relat. Disord., 11, 341-347.
95. Rawal, N., Periquet, M., Lohmann, E., Lucking, C.B., Teive, H.A., Ambrosio, G., Raskin, S., Lincoln, S., Hattori, N., Guimaraes, J. et al. (2003) New parkin mutations and atypical phenotypes in families with autosomal recessive parkinsonism. Neurology, 60, 1378-1381.